Clinical trial
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
NCT00014352
Study timeline
Study start (unknown)2000-09-01Date precision: month
Registry last updated2013-01-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Thromboembolismunresolved
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
ketoconazoleDRUG · verified · RxNorm: ketoconazole
warfarinDRUG · verified · RxNorm: warfarin
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00014352 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.